MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 112 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,000 | +129.2% | 3,490 | +88.5% | 0.00% | – |
| Q2 2023 | $48,000 | +50.0% | 1,851 | +40.1% | 0.00% | – |
| Q1 2023 | $32,000 | -39.6% | 1,321 | -51.7% | 0.00% | – |
| Q4 2022 | $53,000 | +657.1% | 2,734 | +687.9% | 0.00% | – |
| Q3 2022 | $7,000 | +75.0% | 347 | +66.8% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 208 | -38.6% | 0.00% | – |
| Q1 2022 | $8,000 | -46.7% | 339 | -66.0% | 0.00% | – |
| Q4 2021 | $15,000 | +150.0% | 996 | +230.9% | 0.00% | – |
| Q3 2021 | $6,000 | -40.0% | 301 | -49.8% | 0.00% | – |
| Q2 2021 | $10,000 | +233.3% | 600 | +252.9% | 0.00% | – |
| Q1 2021 | $3,000 | – | 170 | +1114.3% | 0.00% | – |
| Q3 2020 | $0 | – | 14 | +7.7% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 13 | -95.1% | 0.00% | – |
| Q1 2020 | $4,000 | +100.0% | 267 | +238.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 79 | -20.2% | 0.00% | – |
| Q3 2019 | $1,000 | – | 99 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |